Invention Grant
- Patent Title: Therapeutic agent for cancer
- Patent Title (中): 癌症治疗剂
-
Application No.: US12449377Application Date: 2008-02-07
-
Publication No.: US09045556B2Publication Date: 2015-06-02
- Inventor: Keiko Udaka , Masahide Ishibashi
- Applicant: Keiko Udaka , Masahide Ishibashi
- Applicant Address: JP Tokyo JP Osaka JP Kochi
- Assignee: NEC Corporation,The Research Foundation for Microbial Disease of Osaka University,National University Corporation Kochi University
- Current Assignee: NEC Corporation,The Research Foundation for Microbial Disease of Osaka University,National University Corporation Kochi University
- Current Assignee Address: JP Tokyo JP Osaka JP Kochi
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2007-028081 20070207
- International Application: PCT/JP2008/052070 WO 20080207
- International Announcement: WO2008/096831 WO 20080814
- Main IPC: A61K39/10
- IPC: A61K39/10 ; A61K39/00 ; A61K39/04 ; C07K14/47 ; A61K39/02
Abstract:
The present invention provides an adjuvant for cancer antigen peptide vaccines and virus antigen peptides, containing a pertussis vaccine as a primary ingredient. The present invention also provides a therapeutic agent for a cancer or viral infectious disease, and a prophylactic agent for metastasis or recurrence of cancer or onset of virus-induced tumor, containing a cancer antigen peptide or virus antigen peptide and a pertussis vaccine. A pertussis vaccine that can be suitably used is a whole cell body pertussis vaccine. The agents of the present invention can be safely administered in a plurality of doses.
Public/Granted literature
- US20100322968A1 THERAPEUTIC AGENT FOR CANCER Public/Granted day:2010-12-23
Information query
